Gut and oral microbiome profiles in patients with obesity and ischemic heart disease
This study demonstrates that obesity and IHD are linked to unique microbiota alterations. Microbial dysbiosis may contribute to the pathogenesis of these conditions and should be considered as a therapeutic target in the development of personalized treatment strategies of the obesity and associated cardiovascular complications.
Authors
- E.N. Livantsova (ORCID: https://orcid.org/0000-0001-5670-9607)
- А. В. Стародубова (ORCID: https://orcid.org/0000-0001-9262-9233)
- N. Shaposhnikova
- Tatiana V. Kirichenko (ORCID: https://orcid.org/0000-0002-2899-9202)
- Georgy Leonov (ORCID: https://orcid.org/0000-0002-5632-7040)
- Yuliya V. Markina (ORCID: https://orcid.org/0000-0002-3781-6340)
- Mariam Bagheri Ekta (ORCID: https://orcid.org/0000-0001-7952-1068)
- Y. Varaeva (ORCID: https://orcid.org/0000-0002-5274-2773)
- Stanislav I. Koshechkin (ORCID: https://orcid.org/0000-0002-7389-0476)
- Alexander N. Orekhov (ORCID: https://orcid.org/0000-0002-3318-4681)
- Denis P. Fotin
- Dmitry Nikityuk
Institutions
- Federal Research Centre of Nutrition and Biotechnology (RU)
- Pirogov Russian National Research Medical University (RU)
- Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences (RU)
- Moscow State University of Technologies and Management named after K.G. Razumovskiy (RU)
- Russian Scientific Center of Surgery (RU)
Publication Details
- Journal
- Frontiers in Cellular and Infection Microbiology
- Published
- 2025-12-12
- DOI
- https://doi.org/10.3389/fcimb.2025.1695279
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Russian Science Foundation